Pages that link to "Q58051415"

The following pages link to Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease (Q58051415):

Displaying 12 items.

• Modulation of actin dynamics by Rac1 to target cognitive function (Q26820813) (← links)
• EHT 1864, a small molecule inhibitor of Ras-related C3 botulinum toxin substrate 1 (Rac1), attenuates glucose-stimulated insulin secretion in pancreatic β-cells. (Q35236262) (← links)
• Deletion of Rac1GTPase in the Myeloid Lineage Protects against Inflammation-Mediated Kidney Injury in Mice (Q38634830) (← links)
• High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy (Q36646597) (← links)
• Renal mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-associated pathways. (Q38292348) (← links)
• The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy (Q38374536) (← links)
• The kidney in obesity (Q38429861) (← links)
• Aldosterone and the Mineralocorticoid Receptor: Risk Factors for Cardiometabolic Disorders (Q38525979) (← links)
• Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864. (Q40920822) (← links)
• Sex-Specific Mechanisms of Resistance Vessel Endothelial Dysfunction Induced by Cardiometabolic Risk Factors. (Q49913747) (← links)
• Vascular Mineralocorticoid Receptor: Evolutionary mediator of wound healing turned harmful by our modern lifestyle (Q58086049) (← links)
• Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study (Q93025188) (← links)